期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Pharmacogenetics and Genomics LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||||||||||||||||||
期刊簡稱 | PHARMACOGENET GENOM | ||||||||||||||||||||||||||||||||
ISSN | 1744-6872 | ||||||||||||||||||||||||||||||||
E-ISSN | 1744-6880 | ||||||||||||||||||||||||||||||||
h-index | 134 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 5.90%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://journals.lww.com/jpharmacogenetics/pages/default.aspx | ||||||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/PGEN | ||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||||||
創刊年 | 2005 | ||||||||||||||||||||||||||||||||
每年文章數 | 23每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 8.79% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1744-6872%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 5% | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Pharmacogenetics and Genomics] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:18:02 評論於 Almost all submitted manuscripts that meet the academic standards for publication are required to be returned to authors for revision before publication. This may involve modifying the wording, editing the format, condensing the length of the article, redesigning tables, improving the quality of illustrations, and restricting the use of irregular abbreviations. However, a manuscript returned to the author for revision does not guarantee acceptance. Ultimately, acceptance depends on whether the author's modifications to the key content and expression of the article meet the requirements of the reviewers and editors. Typically, materials returned to authors for revision include the original manuscript, reviewers' comments, and a covering letter from the editor. Upon receiving the revised manuscript, authors should carefully read the revision letter and reviewers' comments. They should then consider whether they are able or willing to accept the reviewers' or editors' suggestions and revise the manuscript accordingly. The likelihood of acceptance can be determined from the responses of the editor and reviewers. Revisions should not be rushed; authors should carefully read and understand the reviewers' questions. Each comment from a reviewer should be addressed individually, modifications to the revised manuscript should be clearly marked, and a letter to the editor should express gratitude for the feedback and explain any changes made in response to their suggestions(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:03:49 評論於 Submission completed - Format review - Editor initial review - Peer review - Review completed - Editor final review - Author revision(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:40:22 評論於 What is the process for manuscript reviewing?(0) 讚! | 北国博达 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 08:48:07 評論於 What is the process of recycling?(0) 讚! | 陶宜三岁啦 |
作者: 梅梅姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-25 09:18:21 評論於 How many days does the first trial usually take???(0) 讚! | 梅梅姑娘 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 15:26:44 評論於 It's too harsh! It dropped so much, who dares to invest in the future?(0) 讚! | 凌霄高洁 |
作者: 控鹤宝娥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-07 15:10:45 評論於 How long does the second review process of this journal usually take? Also, what is the acceptance rate for papers that are recommended for acceptance with major revision after the first review?(0) 讚! | 控鹤宝娥 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-11-26 10:34:01 評論於 The difficulty was too high, so it wasn't submitted for review for a month and was dropped directly(0) 讚! | 凌霄高洁 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-09-09 19:58:00 評論於 The old journal of genetic pharmacology was formerly called pharmacogenetics. It was renamed before and the influence factor was high. It is the best publication of the discipline of genetic pharmacology. It is not so strong now.PHARMACOGENOMICS JOURNAL Beyond Because the field is increasingly emphasizing the sequencing of multiple snp sites, large-scale statistical analysis(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-08-09 23:21:47 評論於 Submitting articles to magazines is difficult and time-consuming(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 12:41:48 評論於 Research Focus: Genomics(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-05-26 12:07:56 評論於 Ugh, don't even think about writing articles like this if you're not a big shot(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-05-07 20:36:46 評論於 The German customs are too slow, it has been more than a year and the article is still tragically missing(0) 讚! | 凌霄高洁 |
作者: 摩柯珺俐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-04-01 23:09:26 評論於 Review speed: 12.0 | Submission success rate: 5.0 Experience sharing: extremely slow speed and high difficulty(0) 讚! | 摩柯珺俐 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us